Skip to main content
Praveen Raju, MD, Child Neurology, New York, NY, New York-Presbyterian Hospital

PraveenRajuMDPhD

Child Neurology New York, NY

Associate Professor of Neurology and Pediatrics and Director, Pediatric Neurology Residency Program at the Icahn School of Medicine at Mount Sinai

Dr. Raju is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Raju's full profile

Already have an account?

Education & Training

  • Children's Hospital/Beth Israel Deaconess Medical Center/Harvard Medical School
    Children's Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 2003 - 2006
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2001 - 2003
  • University of Pennsylvania School of Medicine
    University of Pennsylvania School of MedicinePh.D., 1992 - 2001
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2001
  • University of Pennsylvania
    University of PennsylvaniaB.A., 1989 - 1992

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - Present
  • NY State Medical License
    NY State Medical License 2006 - 2025
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Awards, Honors, & Recognition

  • K08 Clinical Scientist Development Award NIH/NINDS, 2009
  • Pediatric Scientist Development Program (PSDP) Fellow NIH/NICHD, 2006-2009
  • Society for Penn Medical Scholars University of Pennsylvania School of Medicine, 1992-2001
  • Join now to see all

Publications & Presentations

Journal Articles

  • In vivo Mn-Enhanced MRI for early tumor detection and growth rate analysis in a mouse medulloblastoma model  
    Suero-Abreu GA, Raju GP, Aristizabal O, Volkova E, Houston EJ, Pham D, Wojcinski A, Szulc KU, Joyner AL, Turnbull DH, Neoplasia, 1/1/2014
  • Clinical, electrophysiologic, and pathologic findings in an adolescent with uremic neuropathy  
    Ho DT, Rodig NM, Kim HB, Lidov HGW, Shapiro FD, Raju GP, Kang PB, Pediatric Transplantation, 1/1/2012
  • MASTR: A technique for Mosaic mutant Analysis with Spatial and Temporal control of Recombination using conditional floxed alleles in mice  
    Lao Z, Raju GP, Bai B, Joyner AL, Cell Reports, 1/1/2012
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Early Detection and Tumor Characterization of a Novel Sporadic Model of Shh-driven Medulloblastoma using Contrast Enhanced MRI.
    Suero-Abreu G, Raju GP, Aristizabal O, Pham D, Houston EJ, Volkova E, Joyner Al, Turnbull DH, American Association for Cancer Research (AACR) Meeting, Washington, DC, 1/1/2013
  • Preclinical Assessment of Arsenic Trioxide and Resistance Mechanisms Using a Novel Mouse Model of Sporadic Medulloblastoma.
    Maganty, Mi J, and Raju GP, American Brain Tumor Association Meeting, Chicago, IL, 1/1/2013
  • Preclinical Assessment of GANT61 and Resistance Mechanisms Using a Novel Mouse Model of Sporadic Medulloblastoma.
    Wu YL, Mi J, and Raju GP, Child Neurology Society Meeting, Austin, TX, 1/1/2013
  • Join now to see all

Lectures

  • "Novel preclinical approaches to understanding brain tumor formation, intratumoral heterogeneity, and treatment resistance" 
    1/1/2014
  • "Novel translational approaches for improving outcomes of brain tumor patients" 
    1/1/2013
  • "Novel Translational Approaches for Pediatric Brain Tumors" 
    1/1/2013
  • Join now to see all

Press Mentions

  • New Anti-Cancer Drug Delivery Technology for Brain Tumors Is More Effective, Less Toxic [STUDY]
    New Anti-Cancer Drug Delivery Technology for Brain Tumors Is More Effective, Less Toxic [STUDY]March 3rd, 2023
  • Nanoparticles Target Medulloblastoma Tumor to Improve Drug Therapy and Reduce Toxicity
    Nanoparticles Target Medulloblastoma Tumor to Improve Drug Therapy and Reduce ToxicityMarch 3rd, 2023
  • Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children
    Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in ChildrenFebruary 27th, 2023
  • Join now to see all

Professional Memberships

  • Child Neurology Society
    Member

Hospital Affiliations